Cytokines and inflammatory pathways (indirect modulation)

Cytokines and inflammatory pathways (indirect modulation) refers to a therapeutic approach where the inflammatory environment is modified through the paracrine activity of administered cells or biological agents, rather than by binding to a specific molecular target. This mechanism is most commonly associated with Mesenchymal Stem Cells (MSCs), which act as injury drugstores by sensing inflammatory signals and responding with the secretion of a diverse array of immunomodulatory factors, including anti-inflammatory cytokines (e.g., IL-10, TGF-beta) and extracellular vesicles (Caplan & Correa, 2011, Cell Stem Cell). These secreted factors interact with various immune cells, such as T-cells and macrophages, to promote an anti-inflammatory state and facilitate tissue repair (Galipeau & Sensébé, 2018, Nature Medicine). Because this approach targets the broader inflammatory milieu rather than a single protein, it is particularly useful for complex, multi-factorial diseases like Graft-versus-Host Disease (GvHD) and Crohn's disease. However, the indirect nature of this modulation presents significant challenges in characterizing the precise mechanism of action and ensuring consistent therapeutic efficacy across different patient populations (Pittenger et al., 2019, NPJ Regenerative Medicine).

Other names

Paracrine signaling modulationSecretome-mediated immunomodulationIndirect cytokine regulationMSC-mediated paracrine signaling

Indirect modulation of the inflammatory environment through the secretion of paracrine factors (cytokines, growth factors, extracellular vesicles) that alter the behavior of neighboring immune and stromal cells (Caplan & Correa, 2011).